![](/wp-content/uploads/2018/10/DM45JgCUS32bmcNQbm7D.png)
$599
Novo Suspends Ph1 Stable Glucagon Analog Study
The CT.gov record for Novo’s Ph1 stable glucagon analog study (NN9030) has been updated, and the trial is now listed as “Suspended (Evaluation of data).” Below, FENIX provides potential scenarios for the recruitment suspension.